成人免费xx,国产又黄又湿又刺激不卡网站,成人性视频app菠萝网站,色天天天天

Imiquimod

Imiquimod Struktur
99011-02-6
CAS-Nr.
99011-02-6
Englisch Name:
Imiquimod
Synonyma:
ALDARA;R-837;TMX101;S-26308;TMX 101;TMX-101;Zyclara;imiqimod;imiquimo;Miquimod
CBNumber:
CB2664655
Summenformel:
C14H16N4
Molgewicht:
240.3
MOL-Datei:
99011-02-6.mol

Imiquimod Eigenschaften

Schmelzpunkt:
292-294°C
Siedepunkt:
456.7±48.0 °C(Predicted)
Dichte
1.28±0.1 g/cm3(Predicted)
storage temp. 
Keep in dark place,Inert atmosphere,Store in freezer, under -20°C
L?slichkeit
DMSO: soluble
pka
6.28±0.30(Predicted)
Aggregatzustand
White solid
Farbe
White
Wasserl?slichkeit
Soluble in dimethyl sulfoxide and dimethyl formamide. Slightly soluble in water. Insoluble in ethanol.
maximale Wellenl?nge (λmax)
245nm(H2O/MeOH)(lit.)
Merck 
14,4922
Stabilit?t:
Incompatible with strong oxidizing agents.
InChIKey
DOUYETYNHWVLEO-UHFFFAOYSA-N
CAS Datenbank
99011-02-6(CAS DataBase Reference)
Sicherheit
  • Risiko- und Sicherheitserkl?rung
  • Gefahreninformationscode (GHS)
Kennzeichnung gef?hrlicher T,Xi
R-S?tze: 25-36/37/38
S-S?tze: 26-45-36/37/39-27
RIDADR  UN 2811 6.1/PG 3
WGK Germany  3
RTECS-Nr. NJ5903450
HazardClass  6.1
PackingGroup  III
HS Code  29339900
Giftige Stoffe Daten 99011-02-6(Hazardous Substances Data)
Bildanzeige (GHS) GHS hazard pictograms
Alarmwort Achtung
Gefahrenhinweise
Code Gefahrenhinweise Gefahrenklasse Abteilung Alarmwort Symbol P-Code
H301 Giftig bei Verschlucken. Akute Toxizit?t oral Kategorie 3 Achtung GHS hazard pictogramssrc="/GHS06.jpg" width="20" height="20" /> P264, P270, P301+P310, P321, P330,P405, P501
H315 Verursacht Hautreizungen. Hautreizung Kategorie 2 Warnung GHS hazard pictogramssrc="/GHS07.jpg" width="20" height="20" /> P264, P280, P302+P352, P321,P332+P313, P362
H319 Verursacht schwere Augenreizung. Schwere Augenreizung Kategorie 2 Warnung GHS hazard pictogramssrc="/GHS07.jpg" width="20" height="20" /> P264, P280, P305+P351+P338,P337+P313P
Sicherheit
P264 Nach Gebrauch gründlich waschen.
P264 Nach Gebrauch gründlich waschen.
P270 Bei Gebrauch nicht essen, trinken oder rauchen.
P280 Schutzhandschuhe/Schutzkleidung/Augenschutz tragen.
P301+P310 BEI VERSCHLUCKEN: Sofort GIFTINFORMATIONSZENTRUM/Arzt/... (geeignete Stelle für medizinische Notfallversorgung vom Hersteller/Lieferanten anzugeben) anrufen.
P302+P352 BEI BERüHRUNG MIT DER HAUT: Mit viel Wasser/... (Hersteller kann, falls zweckm??ig, ein Reinigungsmittel angeben oder, wenn Wasser eindeutig ungeeignet ist, ein alternatives Mittel empfehlen) waschen.
P305+P351+P338 BEI KONTAKT MIT DEN AUGEN: Einige Minuten lang behutsam mit Wasser spülen. Eventuell vorhandene Kontaktlinsen nach M?glichkeit entfernen. Weiter spülen.

Imiquimod Chemische Eigenschaften,Einsatz,Produktion Methoden

R-S?tze Betriebsanweisung:

R25:Giftig beim Verschlucken.
R36/37/38:Reizt die Augen, die Atmungsorgane und die Haut.

S-S?tze Betriebsanweisung:

S26:Bei Berührung mit den Augen sofort gründlich mit Wasser abspülen und Arzt konsultieren.
S45:Bei Unfall oder Unwohlsein sofort Arzt zuziehen (wenn m?glich, dieses Etikett vorzeigen).
S36/37/39:Bei der Arbeit geeignete Schutzkleidung,Schutzhandschuhe und Schutzbrille/Gesichtsschutz tragen.
S27:Beschmutzte, getr?nkte Kleidung sofort ausziehen.

Beschreibung

Aldara was launched in the US for the topical treatment of genital warts caused by human papillomavirus (HPV). It can be prepared in a six step approach beginning with the nucleophilic substitution of 4-chloro-3-nitroquinolone with isobutylamine or via a thermal electrocyclic ring closure of 1 - and 2-azahexatriene systems. Aldara has antiviral and antitumor properties, with the former activity arising from the induction of cytokines, in particular, INF-α. Aldara also induces TNF-γ, IL-1α, IL-1β, IL-1ra, IL-6, IL-8, IL-10, GM-CSF, G-CSF and MID-la formation 1-4 hr after stimuli. The exact cells responsible for the response have not been determined, however, it is not activating T lymphocytes, NK cells, B lymphocytes, or dendritic stem cells but monocytes (CD14+, CD36+, HLA-DR+, HLA-DQ±, CD19-, CD16- and CD23-) are partly responsible. The speculation is that Aldara may interact with a kinase modulating the transduction pathway leading to cytokine genes. There is no direct antiviral activity (induction of IFN does not follow true dose response) and it is not mutagenic. The hydroxylated metabolite also induces IFN-α.

Chemische Eigenschaften

White to off white crystalline powder

Verwenden

Imiquimod is a caspase 3 activator which acts as an immunomodulator and displays antiviral and anti-tumor activity. It is a patient-applied cream used for the treatment of genital warts and basal cell carcinoma. It is also used to cure actinic keratosis on the face and scalp. It belongs to a group of drugs called immune response modifiers, which work by activating the immune system to fight abnormal skin growth.

Indications

Imiquimod (Aldara) is a topical immune response modifier approved for the treatment of anogenital warts (condylomata acuminata). The exact mechanism of action is unknown; it has no direct antiviral activity in vitro. It is thought to work in vivo by inducing the production of tumor necrosis factor (TNF α ), interferons (IFN)α and γ , and other cytokines with antiviral activity. It may also be useful for treatment of other types of warts, molluscum contagiosum, and certain forms of skin cancer. Local irritant reactions related to the frequency of application are common.

Pharmazeutische Anwendungen

An imidazoquinoline used for the treatment of genital and perianal warts. While the mechanism of action is not precisely known, it is thought to induce interferon. It has no direct antiviral activity. The 5% cream applied three times a week for up to 16 weeks resulted in total wart clearance in 50% of patients, with a better response in women than in men. Local reactions are common and include erythema, erosion, excoriation and edema.

Biologische Aktivit?t

Immunomodulator that displays antiviral and antitumor activity. Acts as a Toll-like receptor 7 (TLR-7) agonist; stimulates proinflammatory cytokine production and activates NF- κ B.

Mechanism of action

Imiquimod (Aldara) is an imidazoquinolone amine that is an immune responsemodifier. Its exact mechanism is unknown in the topical treatment of HPV and molluscum contagiosum but may be related to the immunomodulating effect of the drug. It is also effective in the treatment of actinic keratoses and superficial basal cell carcinoma.
It induces production of a variety of cytokines and can enhance cell-mediated cytolytic antiviral activity. It is a rapid and potent inducer of interferon-α, interleukin?1 α and β, interleukin 6, interleukin 8, tumor necrosis factor-α, granulocyte-macrophage colony-stimulating factor, and granulocyte colonystimulating factor. Systemic absorption is minimal. It is generally well tolerated. Adverse local reactions include erythema, erosion, excoriation, flaking, and edema of the treatment sites.

Imiquimod Upstream-Materialien And Downstream Produkte

Upstream-Materialien

Downstream Produkte


Imiquimod Anbieter Lieferant Produzent Hersteller Vertrieb H?ndler.

Global( 531)Lieferanten
Firmenname Telefon E-Mail Land Produktkatalog Edge Rate
Shaanxi Dideu Medichem Co. Ltd
+86-29-81148696 +86-15536356810
1022@dideu.com China 3882 58
Hebei Dangtong Import and export Co LTD
+86-13910575315 +86-13910575315
admin@hbdangtong.com China 1000 58
Anhui Ruihan Technology Co., Ltd
+8617756083858
daisy@anhuiruihan.com China 973 58
HEBEI SHENGSUAN CHEMICAL INDUSTRY CO.,LTD
+86-15350851019 +86-15383190639
admin@86-ss.com China 1000 58
Capot Chemical Co.,Ltd.
+86-(0)57185586718 +86-13336195806
sales@capot.com China 29791 60
Henan Tianfu Chemical Co.,Ltd.
+86-0371-55170693 +86-19937530512
info@tianfuchem.com China 21634 55
Shanghai Time Chemicals CO., Ltd.
+86-021-57951555 +8617317452075
jack.li@time-chemicals.com China 1803 55
ATK CHEMICAL COMPANY LIMITED
+undefined-21-51877795
ivan@atkchemical.com China 32951 60
career henan chemical co
+86-0371-86658258 +8613203830695
sales@coreychem.com China 29885 58
Hubei Jusheng Technology Co.,Ltd.
18871490254
linda@hubeijusheng.com CHINA 28172 58

99011-02-6()Verwandte Suche:


  • R-837
  • S-26308
  • 1-(2-Methylpropyl)-1H-imidazo[4,5-c]quinolin-4-amine, R-837, S-26308, Aldara
  • IMIQUIMOD /4-AMINO- 1-ISOBUTYL-1H-IMIDAZO[4,5-C]QUINOLINE
  • 1-(2-methylpropyl)-1H-imidazo(4,5-quinolin-4-amine)
  • 1-(2-METHYLPROPYL)-1H-IMIDAZO[4,5-C]QUINOLIN-4-AMINE
  • 4-amino- 1-isobutyl-1h-imidazo[4,5-c]quinoline
  • IMIQUIMOD
  • 1-isoButyl-1H-Inudazole[4.5-c]quinoline-4-amine
  • 1-(2-Methylpropyl)-1H-imidazole[4,5-c]quinoline-4-amine
  • 1H-Imidazo[4,5-c]quinolin-4-amine, 1-(2-methylpropyl)-
  • IMiquiMod(Aldara,R 837)
  • Imiquimod (200 mg)
  • 1-Isobutyl-1H-imidazo[4,5-c]quinolin-4-amine 4-Amino-1-isobutyl-1H-imidazo[4,5-c]quinoline
  • IMiquiMod (Aldara)
  • 1-isobutyl-1H-iMidazo[4,5-c]quinolin-4-aMine
  • Imiquimod solution,100ppm
  • -1H-imidazo[4,5-c]quinoL
  • 4-Amino-1-isobutyL
  • Imiquimod USP/EP/BP
  • Imiquimodr
  • Imiquimod cream
  • Imiquimod D7Q: What is Imiquimod D7 Q: What is the CAS Number of Imiquimod D7 Q: What is the storage condition of Imiquimod D7 Q: What are the applications of Imiquimod D7
  • Imiquimod-d9Q: What is Imiquimod-d9 Q: What is the CAS Number of Imiquimod-d9
  • ImiquimodQ: What is Imiquimod Q: What is the CAS Number of Imiquimod Q: What is the storage condition of Imiquimod Q: What are the applications of Imiquimod
  • Imiquimod for cell culture, 98%
  • Imiquimod (1338313)
  • Imiquimod - CAS 99011-02-6 - Calbiochem
  • Imiquimod-d9
  • Imiquimod,98%
  • imiqimod
  • Imiquimod ( Aldara ), 1-(2-methylpropyl)-1H-imidazo [4,5-c] quinolin-4-amine
  • Imiquimod, 99%, a toll-like receptor 7 agonist
  • Imiquimod>
  • Imiguimode
  • ALDARA
  • imiquimo
  • Miquimod
  • TMX 101
  • TMX101
  • TMX-101
  • Zyclara
  • 99011-02-6
  • C14H16N4
  • Cell Signaling and Neuroscience
  • Cell Biology
  • Apoptosis Inducers
  • Apoptosis and Cell Cycle
  • BioChemical
  • Furans ,Coumarins
  • Other APIs
  • ALDARA
  • Intermediates & Fine Chemicals
  • Pharmaceuticals
  • Active Pharmaceutical Ingredients
  • API
Copyright 2019 ? ChemicalBook. All rights reserved